Subgingival microflora and periodontitis.

PubWeight™: 2.30‹?› | Rank: Top 2%

🔗 View Article (PMID 130475)

Published in J Periodontal Res on February 01, 1976

Authors

B L Williams, R M Pantalone, J C Sherris

Articles citing this

Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis. Infect Immun (1981) 2.84

Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism. Infect Immun (1979) 2.57

Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae. Infect Immun (1984) 1.92

Bacteriology of dental abscesses of endodontic origin. J Clin Microbiol (1983) 1.65

Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets. J Clin Microbiol (1979) 1.63

Coaggregation of human oral Cytophaga species and Actinomyces israelii. Infect Immun (1983) 1.57

Capacity of anaerobic bacteria from necrotic dental pulps to induce purulent infections. Infect Immun (1979) 1.55

Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces. Infect Immun (1981) 1.45

Morphology and ultrastructure of oral strains of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus. Infect Immun (1980) 1.42

Human immune responses to oral microorganisms: patterns of systemic antibody levels to Bacteroides species. Infect Immun (1986) 1.26

New medium for isolation of Actinomyces viscosus and Actinomyces naeslundii from dental plaque. J Clin Microbiol (1978) 1.20

Fatty acid composition of gliding bacteria: oral isolates of Capnocytophaga compared with Sporocytophaga. Infect Immun (1979) 1.06

Lymphoproliferative responses to oral bacteria in humans with varying severities of periodontal disease. Infect Immun (1980) 1.00

In vitro stimulation of immunoglobulin production from human peripheral blood lymphocytes by a soluble preparation of Actinomyces viscosus. Infect Immun (1981) 1.00

Morphological features and functional properties of human fibroblasts exposed to Actinomyces viscosus substances. Infect Immun (1978) 0.98

Polyclonal activation of human peripheral blood B lymphocytes by Fusobacterium nucleatum. Infect Immun (1983) 0.98

Identification and analysis of fipA, a Fusobacterium nucleatum immunosuppressive factor gene. Infect Immun (1996) 0.96

Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect Immun (1995) 0.95

In vivo and in vitro studies on possible pathogenic mechanisms of Actinomyces viscosus. Infect Immun (1976) 0.92

Salivary receptors for GalNAc beta-sensitive adherence of Actinomyces spp.: evidence for heterogeneous GalNAc beta and proline-rich protein receptor properties. Infect Immun (1992) 0.92

Cell-associated levan of Actinomyces viscosus. Infect Immun (1978) 0.91

Survival of gram positive anaerobic cocci on swabs and their isolation from the mouth and vagina. J Clin Pathol (1986) 0.90

Immune labeling of certain strains of Actinomyces naeslundii and Actinomyces viscosus by fluorescence and electron microscopy. Infect Immun (1979) 0.89

Assessment of serum antibody patterns and analysis of subgingival microflora of members of a family with a high prevalence of early-onset periodontitis. Infect Immun (1985) 0.83

Effects of anaerobiosis and aerobiosis on interactions of human polymorphonuclear leukocytes with the dental plaque bacteria Streptococcus mutans, Capnocytophaga ochracea, and Bacteroides gingivalis. Infect Immun (1991) 0.83

Should patients with hip joint prosthesis receive antibiotic prophylaxis before dental treatment? J Oral Microbiol (2010) 0.82

Survival of bacteria from human dental plaque under various transport conditions. J Clin Microbiol (1977) 0.81

Purification and biochemical properties of a bacteriocin from Actinobacillus actinomycetemcomitans. Infect Immun (1987) 0.79

Immunological properties of Actinomyces viscosus: comparison of blastogenic and adjuvant activities. Infect Immun (1980) 0.79

Purification and characterization of levanase from Actinomyces viscosus ATCC 19246. Infect Immun (1987) 0.79

Nonsporing, anaerobic, gram-positive rods in saliva and the gingival crevice of humans. Appl Environ Microbiol (1978) 0.79

Sensitization with Fusobacterium nucleatum targets antibody-dependent cellular cytotoxicity to mammalian cells. Infect Immun (1986) 0.78

Evaluation of subgingival microflora in all ceramic restorations with subgingival heavy chamfer finish lines. J Indian Prosthodont Soc (2012) 0.75

Isolation and characterization of Actinomyces viscosus mutants defective in binding salivary proline-rich proteins. Infect Immun (1992) 0.75

Identification and preliminary characterization of a major heat-stable surface antigen of Actinomyces israelii by two-dimensional (crossed) immunoelectrophoresis. Infect Immun (1983) 0.75

Antibody reactive with Peptostreptococcus micros in the sera of patients with periodontal disease. J Clin Microbiol (1982) 0.75

Improved procedure for transport of dental plaque samples and other clinical specimens containing anaerobic bacteria. J Clin Microbiol (1979) 0.75

Role of macrophages in the lymphocyte response to Actinomyces viscosus. Infect Immun (1982) 0.75

Articles by these authors

Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00

Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 40.37

Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12

Comparative study of the efficacy of seven paper-reagent strips and conventional biochemical tests in identifying gram-negative organisms. Appl Microbiol (1969) 8.23

Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65

Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance. Antimicrob Agents Chemother (1976) 6.86

Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J Clin Microbiol (1980) 5.99

Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother (1983) 5.10

Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol (1989) 4.03

Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol (1972) 3.55

Methods and significance of in vitro testing of bacterial sensitivity to drugs. Am J Med (1965) 3.50

Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis. Infect Immun (1981) 2.84

Synonymy of strains of Center for Disease Control group DF-1 with species of Capnocytophaga. J Clin Microbiol (1979) 2.29

Laboratory determination of antibiotic susceptibility to ampicillin and cephalothin. Ann N Y Acad Sci (1967) 2.12

Rapidly progressive periodontitis. A distinct clinical condition. Dent Health (London) (1984) 2.08

In vitro response of Enterobacter to ampicillin. Antimicrob Agents Chemother (1979) 2.06

Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity (1996) 1.87

Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science (1995) 1.84

Prevalence of viridans streptococci exhibiting lactose-inhibitable coaggregation with oral actinomycetes. Infect Immun (1983) 1.80

Stability of antibiotics and chemotherapeutics in agar plates. Appl Microbiol (1970) 1.75

Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards. Antimicrob Agents Chemother (1977) 1.72

The clinical significance of Aeromonas hydrophila. Report of two cases. Arch Intern Med (1966) 1.72

Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 1.71

Bacteriology of dental abscesses of endodontic origin. J Clin Microbiol (1983) 1.65

Relationship of early readings of minimal inhibitory concentrations to the results of overnight tests. Antimicrob Agents Chemother (1975) 1.65

Decreased incidence of antibiotic resistance among Staphylococcus aureus. A study in a university hospital over a 9-year period. Ann Intern Med (1968) 1.60

Influence of different media and bloods on results of diffusion antibiotic susceptibility tests. Antimicrob Agents Chemother (1972) 1.59

Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. Nature (1997) 1.54

Climatic modifiers of the response to nitrogen deposition in peat-forming Sphagnum mosses: a meta-analysis. New Phytol (2011) 1.53

Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Mol Cell Biol (2000) 1.51

Glasshouse vs field experiments: do they yield ecologically similar results for assessing N impacts on peat mosses? New Phytol (2012) 1.51

Rapidly progressive periodontitis. A distinct clinical condition. J Periodontol (1983) 1.47

Development of resistance to cephalosporins in clinical strains of Citrobacter spp. Antimicrob Agents Chemother (1984) 1.38

Susceptibility of Neisseria gonorrhoeae to penicillin and tetracycline. Antimicrob Agents Chemother (Bethesda) (1968) 1.36

Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother (1986) 1.32

Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci U S A (1994) 1.22

Capnocytophaga: new genus of gram-negative gliding bacteria. IV. DNA base composition and sequence homology. Arch Microbiol (1979) 1.18

Lymphokine-induced production and release of lysosomal enzymes by macrophages. Proc Natl Acad Sci U S A (1975) 1.11

Prepubertal periodontitis. I. Definition of a clinical disease entity. J Periodontol (1983) 1.11

Subgingival microflora of periodontal patients on tetracycline therapy. J Clin Periodontol (1979) 1.11

Further studies on the structural differences between the isoenzymes of human parotid -amylase. Biochemistry (1971) 1.10

Laboratory studies of a family manifesting premature exfoliation of deciduous teeth. J Clin Periodontol (1986) 1.10

Staphylococcal resistance to antibiotics: origin, measurement, and epidemiology. Ann N Y Acad Sci (1974) 1.08

SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem (1998) 1.06

Changing incidence of antibiotic resistance among Staphylococcus aureus, Escherichia coli, Aerobacter-Klebsiella, and Pseudomonas encountered in a teaching hospital over a 7-year period. Antimicrob Agents Chemother (Bethesda) (1966) 1.05

Antibiotic susceptibility testing by a standardized single disk method. Tech Bull Regist Med Technol (1966) 1.03

Anal carriage as the probable source of a streptococcal epidemic. Lancet (1966) 1.03

The susceptibility of Clostridium perfringens type A to ampicillin and penicillin G in vitro. Chemotherapy (1968) 1.02

Antibiotic susceptibilities of Neisseria Gonorrheae isolates. Northwest Med (1967) 1.01

The sterol content of some protozoa. J Protozool (1966) 1.00

Clinical, microbiological and immunological studies of a family with a high prevalence of early-onset periodontitis. J Periodontol (1984) 0.98

Regulation of ZAP-70 intracellular localization: visualization with the green fluorescent protein. J Exp Med (1997) 0.97

Studies on the interaction between serum bactericidal activity and antibiotics in vitro. Chemotherapy (1970) 0.96

Decreased incidences of resistance to antimicrobial agents among Escherichia coli and Klebsiella-enterobacter. Observations in a university hospital over a 10-year period. Ann Intern Med (1970) 0.94

Use of an immunoperoxidase method for identification of Bacteroides fragilis. J Clin Microbiol (1979) 0.93

Studies on phytosterol biosynthesis. The presence of 4-alpha,14-alpha-dimethyl-delta-8,24(28)-ergostadien-3-beta-ol in grapefruit peel and its co-occurrece with cycloeucalenol in higher plant tissues. Eur J Biochem (1967) 0.93

Interdomain B in ZAP-70 regulates but is not required for ZAP-70 signaling function in lymphocytes. Mol Cell Biol (1999) 0.92

Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests. Antimicrob Agents Chemother (1979) 0.91

Antimicrobial susceptibility testing. Hum Pathol (1976) 0.91

Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.90

Comparison of Telazol, Telazol-ketamine, Telazol-xylazine, and Telazol-ketamine-xylazine as chemical restraint and anesthetic induction combination in swine. Lab Anim Sci (1993) 0.89

Clinical and laboratory studies of a family with a high prevalence of juvenile periodontitis. J Periodontol (1985) 0.89

Electrical impedance measurements in the reading and monitoring of broth dilution susceptibility tests. Antimicrob Agents Chemother (1977) 0.88

ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J Immunol (1997) 0.87

Disseminated osteomyelitis due to "Battey" mycobacteria. Am Rev Respir Dis (1966) 0.87

The demonstration of specific urinary anti-bodies in urinary tract infections caused by Gram-negative bacilli. J Pathol Bacteriol (1966) 0.86

Ischemic preconditioning protects against paraplegia after transient aortic occlusion in the rat. Ann Thorac Surg (2000) 0.86

Long-term effects of tetracycline on the subgingival microflora. J Clin Periodontol (1979) 0.84

Expression of the human alpha1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis. FASEB J (1999) 0.84

Assessment of serum antibody patterns and analysis of subgingival microflora of members of a family with a high prevalence of early-onset periodontitis. Infect Immun (1985) 0.83

Investigation of the role of endotoxin in periapical inflammation. J Endod (1982) 0.82

In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study. Am J Clin Pathol (1979) 0.81

Increasing xylazine dose-enhanced anesthetic properties of telazol-xylazine combination in swine. Lab Anim Sci (1995) 0.80

Anal streptococci. N Engl J Med (1969) 0.79

Graduate training in dermatology. Changing undergraduate curricula and their relationship to postgraduate education. Arch Dermatol (1969) 0.79

A comparison of antimicrobial activity of four disclosant dyes. J Dent Res (1983) 0.78

Effects of short-term administration of metronidazole on the subgingival microflora. J Clin Periodontol (1985) 0.78

Fluorescent antibody staining of group A streptococci: demonstration and elimination of blocking antibody. J Infect Dis (1967) 0.78

Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation (1996) 0.77

The porcine mammary gland as a bioreactor for complex proteins. Ann N Y Acad Sci (1994) 0.77

Reproducibility of control strains for antibiotic susceptibility testing. Antimicrob Agents Chemother (1976) 0.76

Use of mutant Jurkat T cell lines to define human natural killer cell surface receptor signaling pathways. Methods Mol Biol (2000) 0.76

Characterization of the human XPA promoter. Gene (1995) 0.76

Identification and preliminary characterization of a major heat-stable surface antigen of Actinomyces israelii by two-dimensional (crossed) immunoelectrophoresis. Infect Immun (1983) 0.75

Acropachy in a case of thyrotoxicosis. Proc R Soc Med (1967) 0.75

Assessment of behavioral sequelae of traumatic and chemical CNS insult. Arch Clin Neuropsychol (1991) 0.75

Comparison of anesthetic effects of Telazol-xylazine xylazine, Telazol-xylazine-butorphanol, and Telazol-xylazine-azaperone combinations in swine. Contemp Top Lab Anim Sci (1996) 0.75

Long-term effects of tetracycline on the subgingival microflora. J Clin Periodontol (1979) 0.75

Leukocyte function, microflora, and antibody studies of four families with periodontitis. J Periodontal Res (1982) 0.75

The Effects of Injection of Pituitary Extract Immediately after Delivery: (Section of Obstetrics and Gynaecology). Proc R Soc Med (1939) 0.75

Micro-electrophoresis of cowpox and vaccinia viruses in molar sucrose. J Gen Microbiol (1966) 0.75

Influence of pig substitution on milk yield, litter weights, and milk composition of machine milked sows. J Anim Sci (1999) 0.75

The Effects of Injection of Pituitary Extract Immediately after Delivery: (Section of Obstetrics and Gynæcology). Proc R Soc Med (1939) 0.75

Pregnancy complicated by urinary tract infections. Obstet Gynecol (1969) 0.75

Technical note: machine milking of sows--lactational milk yield and litter weights. J Anim Sci (1999) 0.75

Acute diffuse phlegmonous gastritis. Br J Surg (1973) 0.75

Influence of cornual insemination on endometrial damage and microbial flora in the bovine uterus. J Anim Sci (1987) 0.75

Fetal monitoring during labor. Am J Nurs (1970) 0.75

Rate limitations in posttranslational processing by the mammary gland of transgenic animals. Ann N Y Acad Sci (1996) 0.75